eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | pneumocystosis |
| Comorbidity | C0003864|arthritis |
| Sentences | 7 |
| PubMedID- 23212592 | Clinical characteristics and risk factors for pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients. |
| PubMedID- 24495443 | Prophylaxis for pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study. |
| PubMedID- 20824796 | Trends in hospitalizations for pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the us: 1996-2007. |
| PubMedID- 24881737 | Deterioration of the immune response induced by sulfamethoxazole-trimethoprim in a rheumatoid arthritis patient with pneumocystis jirovecii pneumonia. |
| PubMedID- 26396551 | Pneumocystis jirovecii infection causes fulminant interstitial pneumonia (pneumocystis pneumonia, pcp) in patients with rheumatoid arthritis (ra) who are receiving biological and/or nonbiological antirheumatic drugs. |
| PubMedID- 21971942 | Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (ra) and non-ra rheumatic diseases. |
| PubMedID- 25313341 | pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with abatacept. |
Page: 1